stockrowSchrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
Follow SDGR
Alert me
Schrodinger, Inc. (SDGR) Revenue
Schrodinger, Inc.'s revenue for fiscal 2025 was $255.9M, up 23.3% from $207.5M in fiscal 2024. Over the twelve months to 30 September 2026 it was $269.2M. Over the past ten years it has ranged from $55.7M (fiscal 2017) to $255.9M (fiscal 2025) — the current reading is the highest in ten years. Schrodinger, Inc. ranks 19th of 42 Health Information Services companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $255.9M | 23.29% |
| FY2024 | $207.5M | (4.21%) |
| FY2023 | $216.7M | 19.73% |
| FY2022 | $181.0M | 31.19% |
| FY2021 | $137.9M | 27.60% |
| FY2020 | $108.1M | 26.36% |
| FY2019 | $85.5M | 28.37% |
| FY2018 | $66.6M | 19.65% |
| FY2017 | $55.7M | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $64.5M | 9.51% |
| Jun 2026 | $58.9M | 0.52% |
| Mar 2026 | $58.6M | (32.84%) |
| Dec 2025 | $87.2M | 60.58% |
| 27 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| TDOC Teladoc Health, Inc. compare | $2.5B |
| PRVA Privia Health Group, Inc. compare | $2.4B |
| OMCL Omnicell, Inc. compare | $1.2B |
| GDRX GoodRx Holdings, Inc. compare | $785.2M |
| CERT Certara, Inc. compare | $398.7M |
| HSTM HealthStream, Inc. compare | $328.0M |
| OMDA Omada Health, Inc. compare | $309.8M |
| SDGR Schrodinger, Inc. | $269.2M |
| HTFL Heartflow, Inc. compare | $212.1M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on SDGR
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement